Last updated on November 2017


Brief description of study


Detailed Study Description

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder

Clinical Study Identifier: TX81369

Contact Investigators or Research Sites near you

Start Over

Christina Wegerski

Urology Group of New Mexico
Albuquerque, NM USA